Working together to deliver cell and gene therapies for people impacted by serious diseases Learn More Our inspiration Learn More Pipeline Explore R&D pz-cel (prademagene zamikeracel) BLA submitted for investigational autologous, COL7A1 gene-corrected epidermal sheets for RDEB. Learn More ABO-50X Exploring the potential of ABO-50X for the treatment of genetic eye disorders. Learn More Latest News Oct 1, 2024 Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) View Press Release Sep 3, 2024 Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences View Press Release Sep 2, 2024 Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) View Press Release View All Manufacturing at The Elisa Linton Center for Rare Disease Therapies Learn More
